Virtual reality versus in-person progressive muscle relaxation for pregnant people with preeclampsia
Official title: The Effect of Virtual Reality-Based and Face-to-Face Relaxation Programs on Maternal and Fetal Outcomes in Pregnant Women With Preeclampsia
Run by Istanbul University - Cerrahpasa · NCT06893510 · Data updated 2026-11-12
This trial will test whether virtual reality–guided progressive muscle relaxation or face-to-face progressive muscle relaxation better reduces stress and improves maternal and fetal outcomes in hospitalized pregnant people with preeclampsia at or after 26 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 96 (estimated) |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | September 8, 2025 |
| Main results expected | September 1, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT06893510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Hospitalized pregnant individuals aged 18 or older with a singleton viable pregnancy diagnosed with preeclampsia at or beyond 26 weeks who are willing and able to participate and use a VR headset are ideal candidates.
✕Probably not a fit
Patients with HELLP syndrome, eclampsia, fetal distress requiring emergency care, multiple pregnancy, assisted reproductive pregnancies, significant hearing or vision impairment, or a history of vertigo (or who cannot tolerate VR) are unlikely to benefit from the interventions tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Hospitalized pregnant participants with a diagnosis of preeclampsia at gestational age ≥26 weeks are assigned to receive either virtual reality–based progressive muscle relaxation using a VR headset or face-to-face progressive muscle relaxation sessions. The interventions focus on standardized progressive muscle relaxation techniques delivered via VR or by a trained practitioner, with monitoring of maternal blood pressure, stress/anxiety measures, and fetal status. Key exclusions include multiple pregnancy, assisted reproductive conception, hearing/vision impairment, HELLP syndrome, eclampsia, fetal distress requiring emergency intervention, and history of vertigo. The study compares maternal and fetal clinical outcomes and tolerability of the VR intervention versus in-person delivery during the hospitalization period.
Why it matters
Potential benefit: If successful, the intervention could offer a non-drug way to lower stress and blood pressure in preeclampsia and provide a scalable relaxation option that may improve short-term maternal and fetal outcomes.
How similar studies have gone: Progressive muscle relaxation has reduced stress and blood pressure in prior studies, and VR-based relaxation has shown promise in other populations, but VR relaxation is not well tested specifically in preeclampsia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized with a diagnosis of preeclampsia. * Gestational age ≥26 weeks. * 18 years or older. * Singleton and viable pregnancy. * Willing to participate in the study voluntarily. Exclusion Criteria: * Multiple pregnancy. * Pregnancy achieved through assisted reproductive technologies. * Hearing or vision impairment in the pregnant individual. * Fetal distress requiring emergency intervention. * HELLP Syndrome or Eclampsia. * History of vertigo. Withdrawal Criteria: * Cases where live birth does not occur. * Participants who voluntarily withdraw from the study. * Participants whose general health condition deteriorates during the intervention. * Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache). * Participants who do not practice progressive muscle relaxation at least once a week after the intervention.
Where it's running
-
Ümraniye Training and Research Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Ergül Aslan, Prof. Dr. — İstanbul University-Cerrahpaşa
- Study coordinator: Güzin Ünlü Suvari, M.Sc.
- Email: guzin.unlu@ogr.iuc.edu.tr
- Phone: +902165004429
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
-
Use of metformin to prolong pregnancy in preterm preeclampsia in the Netherlands
In pregnant people with preterm preeclampsia, this study tests whether metformin can help them stay pregnant longer compared with placebo.
-
Comparing VR hypnosis, PSiO relaxation glasses, and no relaxation tool to reduce anxiety before orthopedic surgery
This project tests whether virtual reality hypnosis, PSiO relaxation glasses, or no relaxation tool best reduces anxiety in adults before orthopedic surgery under general anesthesia.
-
Reducing stress with virtual reality and binaural beats in adults
This study tests whether short sessions of natural soundscapes, virtual reality nature scenes, and binaural beats can help lower stress in healthy adults.
-
Breathing and VR Nature Videos in Angiography Patients
This trial tests whether breathing meditation with VR nature videos can reduce anxiety and improve comfort for adults undergoing coronary angiography.
-
Support COPD patients with a reality-augmented coach for physical activity
This study tests a reality-augmented coach to guide and motivate adults with COPD to exercise in a real-world setting.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.